![](/img/cover-not-exists.png)
Patients with Type 2 Diabetes Treated with IDegLira Have a Greater Chance of Achieving A1C Targets Without Hypoglycemia and Weight Gain Than with Basal Insulin or Basal-Bolus Therapy, Irrespective of A1C Target
Egede, Leonard E., Bargiota, Alexandra, Cannon, Anthony J., Leiter, Lawrence A., Schiffman, Alisa, Ranthe, Mattis F., Haynes, Marsha, Doshi, AnkurVolume:
42
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/j.jcjd.2018.08.022
Date:
October, 2018
File:
PDF, 80 KB
english, 2018